-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$26.00-27.68% Downside
Veracyte, Inc. Frequently Asked Questions
-
What analysts cover Veracyte, Inc.?
Veracyte, Inc. has been rated by research analysts at Morgan Stanley, Needham in the past 90 days.